A novel
N4,N4-dimethylcytidine
RNA modifications
archaea
epitranscriptome
hyperthermophile
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
05 Nov 2024
05 Nov 2024
Historique:
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
ppublish
Résumé
Ribosome structure and activity are challenged at high temperatures, often demanding modifications to ribosomal RNAs (rRNAs) to retain translation fidelity. LC-MS/MS, bisulfite-sequencing, and high-resolution cryo-EM structures of the archaeal ribosome identified an RNA modification,
Identifiants
pubmed: 39471227
doi: 10.1073/pnas.2405999121
doi:
Substances chimiques
Cytidine
5CSZ8459RP
Methyltransferases
EC 2.1.1.-
RNA, Ribosomal, 16S
0
Archaeal Proteins
0
RNA, Archaeal
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2405999121Subventions
Organisme : NSF (NSF)
ID : 2022065
Organisme : NSF (NSF)
ID : MCB-2124202
Organisme : HHS | NIH (NIH)
ID : R35-GM143963
Organisme : New England Biolabs (NEB)
ID : Not applicable
Organisme : HHS | NIH (NIH)
ID : GM132057
Déclaration de conflit d'intérêts
Competing interests statement:K.A.F., P.S.H., V.T., L.E., J.S., H.P.F., R.C., and T.J.S. do not have any competing financial interests nor conflicts of interest to report. N.D., E.J.W., R.T.F., Y.-L.T., G.B.R., and I.R.C. are employed and funded by New England Biolabs, Inc., a manufacturer and vendor of molecular biology reagents, including nucleic acid modifying and synthesis enzymes. The authors state that this affiliation does not affect their impartiality, objectivity of data generation or interpretation, adherence to journal standards and policies, or availability of data.